In the face of such a severe situation, apart from mutations of HNSCC pan-cancer genes such as TP53, CDKN2A, EGFR and the dysfunction of WNT pathway8, no effective biomarker has been identified to infer HPC progression, prognosis and combined treatment response for HPV-negative patients. Here, EGFR is linked to head and neck squamous cell carcinoma.